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Introduction
Candida albicans is a dimorphic fungus that exists as a
commensal of warm-blooded animals including humans. It
colonizes mucosal surfaces of the oral and vaginal cavities and
the digestive tract and is also able to cause a variety of
infections, depending on the nature of the underlying host
defect. Therefore, C. albicans infections (candidiasis) are very
infrequent in healthy individuals. Candidiasis may be divided
into superficial (such as oral and vaginal thrush and chronic
mucocutaneous candidiasis) and deep-seated (such as Candida-
due myocarditis and acute disseminated Candida septicaemia)
and represent a major clinical problem. For several reasons
(immunosuppressive treatments, long-term catheterization, use
of broad-spectrum antibiotics and longer survival of
immunologically compromised individuals), Candida infections
have increased dramatically over the last two decades.
An interesting feature of C. albicans is its ability to grow
in two different ways; reproduction by budding, forming an
ellipsoid bud, and in hyphal form, which can periodically
fragment and give rise to new mycelia, or yeast-like forms (Fig.
1). Transitions between the two phenotypes can be induced in
vitro in response to several environmental cues such as pH or
temperature, or different compounds such as N-
acetylglucosamine or proline. However, perhaps the most critical
criterion for pathogenicity is the induction of the mycelial form
by serum or macrophages. In addition to the intrinsic biological
interest of this dimorphism, its ability to switch between the
yeast and the hyphal mode of growth has been implicated in
its pathogenicity [22, 60, 63, 101].
In the light of the above, it is obvious that C. albicans is a
major model of pathogenic yeast. Despite this, advances in the
knowledge of the molecular genetics of C. albicans have
proceeded very slowly if compared with those achieved in
conventional yeasts. C. albicans lacks a sexual cycle and is a
diploid organism, which has made it difficult to manipulate it
genetically [78]. Fifteen years ago, it began to become apparent
that C. albicans was a diploid organism and therefore it was
very difficult to obtain mutant strains. However, in the following
years many auxotrophic mutants were obtained and parasexual
genetic methods to analyze them were developed. Also, this
period saw the dawning of basic molecular techniques.
C. albicans molecular biology is mainly based on the
molecular knowledge of Saccharomyces cerevisiae owing to
their similarity and also because many C. albicans genes can
be expressed in Saccharomyces, although not viceversa.
Furthermore, C. albicans shows many peculiarities that do not
have counterparts in Saccharomyces, such as its ability to grow
in hyphal form [78] and its virulence [22], and this is another
reason for the need to develop genetic tools for its study. It is
also of great importance to define molecular targets for the
development of new antifungal agents [28].
Review papers on the molecular biology of C. albicans are
available [57, 64, 85, 111] which address the current advances
made in the understanding of C. albicans molecular genetics.
In addition, a very useful WWW Server on C. albicans research
(http://alces.med.umn.edu/candida.html) has been created by
Dr. Scherer (Univ. Minnesota, St. Paul, MN, USA) in which
information on genetics, physical mapping, sequence data and
other useful resources (methodology, metabolism, morphology,
etc.) about this organism are included.
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Candida albicans: genetics,
dimorphism and pathogenicity
Summary Candida albicans is a dimorphic fungus that causes severe opportunistic
infections in humans. Recent advances in molecular biology techniques applied to
this organism (transformation systems, gene disruption strategies, new reporter
systems, regulatable promoters) allow a better knowledge of both the molecular basis
of dimorphism and the role of specific genes in Candida morphogenesis. These same
molecular approaches together with the development of appropriate experimental
animal models to analyze the virulence of particular mutants, may help to understand
the molecular basis of Candida virulence.
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In this review we shall briefly summarise the work on
Candida classical genetics (mutant isolation, parasexual
genetics and chromosomal reorganisations), the general
strategies used for gene isolation and the molecular tools
currently being developed in C. albicans (transformation
systems, gene disruption strategies and gene reporter systems),
and the use of animal models for studies on its pathogenesis
and the immune response against this yeast. We aim at offering
a concise, basic review of the tools available for studying
the biology and pathogenicity of this yeast. We have
purposefully left out of this review a major aspect for the
pharmaceutical industry: the need for the development of really
effective, non toxic, fungicidal therapeutical agents, since those
currently available in clinical practice are confined to relatively
few chemical classes [28] and resistances are being developed.
It is therefore necessary to find new, selective antifungal targets,
and significant efforts are currently being focused in this
direction.
Genetics
Classical genetics C. albicans classical genetics had a great
impact in the 1980s. Now, in spite of its being out of fashion,
it may still offer clues to the understanding of this yeast. The
diploid nature of C. albicans was deduced from the
determination of its DNA content and the kinetics of
reassociation of denatured total DNA. In addition, it was found
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Fig. 1 Candida albicans dimorphism. (A) Blastospores are unicellular forms of the fungus that divide by budding. (B) In the presence of some environmental
factors, cylindrical outgrowth is initiated on the surface of a blastospore forming a germ tube. (C) Germ tubes grow and septa are laid down behind the extending
apical tip to form a hypha. (D) Hyphal branches and/or secondary branches are produced just behind newly laid-down septa, constituting a micelium.
(E) Secondary blastospores become separated from the filament. The main factors that favour filamentation (yeast ! hypha) are: temperature 35°C, 
pH 7.0, an inoculum of 1 × 106 blastospores/ml, and the presence of different compounds, such as N-acetylglucosamine, proline or serum
that many clinical isolates of C. albicans displayed a strongly
biased auxotroph spectrum after ultraviolet (UV) irradiation
[123]. This was interpreted as the consequence of the natural
heterozygosity of many C. albicans strains for some loci. This
hypothesis was later confirmed from the analysis of sectored
colonies obtained after UV treatment of putative natural
heterozygotes or revertants from mutants isolated by chemical
mutagenesis [92, 94, 124].
Mutant isolation C. albicans diploidy accounts for the
difficulties in obtaining mutant strains. In fact, most mutant
alleles are recessive and therefore should be present in
homozygosity for the mutant phenotype to be shown.
Accordingly, after mutagenesis of a C. albicans wild type strain
(+/+), a mutant heterozygous strain (+/–) for several loci is
generated which must be rendered homozygous (–/–) by either
spontaneous or induced (mainly with the use of UV irradiation)
mitotic recombination. A second round of mutagenesis could
lead also to the homozygous state.
Different mutagenic agents have been used to obtain C.
albicans mutants. The most common are UV irradiation,
methyl-nitro-nitrosoguanidine, ethylmethane-sulfonate and
nitrous acid [45, 93, 106]. Several mutant enrichment
procedures for auxotrophs have been developed, such as
protocols based on amphotericin B treatment [92], inositol
starvation [21] and folate pathway inhibitors [38]. In addition,
morphological mutants have been isolated by using differential
filtration enrichment techniques [10, 31]. With these
procedures, a wide range of mutants has been isolated [91].
Although molecular protocols have now replaced classical
mutant isolation in C. albicans, the former approach may still
provide a source of host strains for direct cloning in 
C. albicans [34, 75], especially as regards the above-reported
processes where S. cerevisiae and C. albicans are clearly
different.
Parasexual genetics There are many examples of the use
of protoplast fusion of C. albicans [30, 68], and all published
protocols are very similar with regard to the use of calcium
salts and polyethylene glycol. Protoplasts from strains to be
analyzed that present appropriate markers (normally auxotroph
markers) can be fused to give fusion products which are selected
in a medium that does not allow the growth of any of the
parental strains. Thus, two kinds of colonies appear on the
regeneration plates: fast-growing stable colonies, corresponding
to uninucleate tetraploid hybrids (probably resulting from the
fusion of two nuclei from both parental strains), and slow-
growing multinucleate colonies or heterokaryons, which are
unstable on complete medium [108]. On minimal medium,
these slow growing colonies develop faster growing sectors,
which could be tetraploid hybrids or aneuploids [107]. These
hybrids are stable and the loss of chromosomes necessary to
come back to the diploid state can be induced by heat shock
treatment [42] or by using the antimicrotubule agent methyl
benzimidazole carbamate [3]. In this way, the full parasexual
cycle of C. albicans can be induced (2n × 2n ! 4n ! 2n).
Molecular biology 
Transformation systems The introduction and stable
maintenance of DNA in C. albicans cells has been one of the
major problems to solve in the genetic manipulation of this
yeast, and only recently have strains and methods been
developed. 
C. albicans seemed to be refractory to any transformation
protocol other than protoplast formation, which has been the
preferred (and for some time the only) method to transform it.
The protocol is similar to that used with S. cerevisiae but with
several modifications [11, 41, 55], due to the stronger nature
of C. albicans cell wall. In recent years, other S. cerevisiae
protocols have been successfully adapted to C. albicans, such
as the lithium acetate [32, 62] or electroporation [51, 79]
techniques. However, they are considerably less efficient than
the protoplast transformation method.
The ideal for C. albicans researchers, at least for those in
clinical practice, would be the ability to manipulate and study
clinical isolates in order to determine their characteristics. To
date, only two dominant selectable markers have been described:
one of them is based on the use of the TCM1 gene, encoding
a S. cerevisiae-modified ribosomal protein, which confers
resistance to the protein synthesis inhibitor trichodermin [41];
the other one is the mycophenolic acid resistance method, more
recently described, which uses the putative C. albicans IMP
dehydrogenase gene (IMH3) in plasmids [51]. Nevertheless,
the classical approach involving the use of auxotrophic mutants
has also been used for C. albicans. These mutants were initially
obtained by multiple rounds of either chemical or physical
mutagenesis. Therefore, they probably bore other mutations
due to the impossibility of crossing strains to isolate the desired
mutation in a clean genetic background. The most widely used
auxotrophs are ura3 strains such as 1006 [35], SGY243 [47]
or cMD716 [32] and ade2 strains such as SGY129 [47] or
hOG300 [94]. Strains bearing multiple markers are SGY484
(ura3 leu2) [46], 792-WC3 (ura2 ade2) [32], 1006 (ura3 lys1
arg4 ser57 MPA1) [35] or 1161 (ura3 lys1 arg4 ser57 gal1
MPA1) [34]. Only when a genetic method was used to obtain
ura3 strains it was possible to compare the phenotypes of strains
bearing different mutations. The generation of C. albicans CAI4
strain as well as an appropriate method for systematic deletion
of the two alleles of each gene present in the genome of C.
albicans (see later) by Fonzi and Irwin has favoured the work
of many other researchers [26]. This strain was constructed by
deleting the URA3 loci by genetic means in a clinically isolated
strain, SC5314, and is currently being used as the standard
strain to generate deletions. More recently, other strains bearing
multiple markers using CAI4 as a basis have been obtained:
RM1000 (ura3 his1), CNC44 (ura3 arg5,6) or CNC43 (ura3
his1 arg5,6) [75].
The first experiments allowing the introduction of DNA
into C. albicans were achieved by homologous integration at
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the ADE2 locus in the genome of the hOG300 strain [55]. The
efficiency per microgram of DNA is normally low (around
0.5–10 transformants/µg DNA) and may, to a certain extent,
be affected by the transcriptional state of the gene of interest
[118]. Although integrative transformation is very useful for
introducing stable traits or for disrupting genes in C. albicans,
an autoreplicative system is necessary for library screening
and DNA recovery. Due to the lack of natural plasmids and to
the inability of 2-micron sequences to replicate autonomously
in C. albicans, the key to the construction of replicative
plasmids has been the isolation of sequences able to promote
autonomous replication in C. albicans (called ARS, for
Autonomously Replicating Sequences). This task was
accomplished by following two opposite directions. Some
researchers isolated ARS by direct screening in C. albicans
by using a genomic library cloned in an integrative vector.
Plasmids able to replicate independently and to produce higher
transformation frequencies were isolated and their DNA
fragments analyzed. This led to the isolation of CARS (C.
albicans ARS) or ARS1 [56]. Plasmids based on this ARS
increase the transformation efficiency up to 103 transformants/µg
DNA. Nevertheless, these plasmids seem to replicate in
multimers and need to be resolved in S. cerevisiae as an
intermediate host [34]. Other authors isolated C. albicans ARS
by using genomic C. albicans DNA libraries constructed in
integrative S. cerevisiae plasmids and searching for stable
plasmids in S. cerevisiae. This strategy allowed the isolation
of two ARS: ARS2 [11] and ARS3 [41]. Both of them stimulate
autonomous replication and increase the transformation
efficiency of plasmids in C. albicans, obtaining frequencies
similar to those obtained with CARS-derived plasmids.
Typically, two types of transformants arise with these plasmids:
cells with faster growth rates, which contain seven to eight
copies of integrated plasmids, and slowly-growing cells with
two or three copies of replicative plasmids [12, 41]. Recently,
a new set of plasmids has been developed by joining both the
ARS2 and ARS3 sequences in a single vector. These plasmids
do not increase the transformation efficiency to a large extent,
but do increase their copy numbers and their mitotic stability,
thus facilitating the use of this yeast in direct gene cloning (see
later). In addition, they do not form multimers as frequently
as others do, and can be isolated directly in Escherichia coli
from C. albicans [86]. To date no C. albicans centromeric
regions have been reported. Table 1 shows several C. albicans
replicating plasmids described until now.
Gene disruption strategies Gene disruption is an essential
tool in host strain construction, gene mapping and functional
analysis. For many years, some biological characteristics of C.
albicans (diploidy and lack of sporulation) hindered the
development of disruption systems. Initially, some strategies
were described that involved the use of UV-enhanced mitotic
recombination on a heterozygous strain (obtained through
homologous recombination with an appropriate gene marker)
to generate homozygosity at the desired locus [47]. In this way,
a leu2 ura3 strain was constructed and its availability allowed
the design of disruption strategies based on both markers that
avoid the random mutagenesis inherent to UV irradiation [58].
A major advance in C. albicans genetic manipulation was
achieved when Fonzi and Irwin [26] adapted a disruption
strategy used in S. cerevisiae. The method involves the use of
C. albicans URA3 flanked by Salmonella typhimurium hisG
genes to provide flanking recombination regions. Following
homologous recombination in the first chromosomal allele,
intrachromosomal excision of the URA3 marker is selected
with the antimetabolite 5-fluoroorotic acid (5-FOA), thus
allowing the recovery of ura3 auxotrophy and enabling a second
round of homologous recombination to disrupt the second
chromosomal allele.
With this system, many C. albicans genes have been
disrupted in their two alleles [2, 32, 33, 36, 62, 69, 74, 81,
82, 102]. Phenotypic studies of the mutants constructed have
been carried out to gain insight into their relationship with
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Table 1 Candida albicans autoreplicative transformation vectors
Name ARSa Gene markers Reference
pMK22 ARS1 URA3 56
pCARS1 ARS1 URA3 46
pRC3925 ARS2 URA3,LEU2 11
pCR2312 ARS2 URA3, LEU2 12
p1041 ARS1 URA3 34
p1110 ARS1 URA3, ARG4 34
p1109 ARS1 URA3, ARG4 34
p1113 ARS1 URA3, LYS1 34
p1334 ARS1 URA3, LYS1 34
pEH7 ARS3 TCM1 41
pCB4 ARS2 ADE1 79
pRM1 ARS2, ARS3 URA3, LEU2 86
pRM10 ARS2, ARS3 URA3 86
pAN8 ARS2, ARS3 ARG5,6 75
aARS sequences are numbered chronologically; thus, ARS1 refers to the CARS sequence isolated by Dr. M. B. Kurtz [56], ARS2 to ARS obtained by 
Dr. R. D. Cannon [12] and ARS3 to Dr. E. Herreros [41].
certain processes of great interest such as dimorphism or
virulence [4, 23, 36, 109].
Some modifications of this disruption strategy have been
reported [105]. This system has been improved [75] with the
utilization of a Ura- His- C. albicans strain (RM1000) as host
strain for the disruption host of the ARG5,6 gene. This allowed
the cotransformation with two different constructions for
simultaneous disruption of both alleles, each with a different
selection marker (URA3 or HIS1). This enabled the construction
of a arg5,6 null mutant in a single step.
Gene reporter systems A suitable gene reporter system is
essential for the study of the function and regulation of C.
albicans-cloned genes. C. albicans decodes the CUG codon
into serine during mRNA translation while in most species it
is decoded into leucine [104]. The use of the non-universal
genetic code by C. albicans represents an important handicap
for the use of heterologous gene reporter systems in this yeast
(E. coli β-galactosidase or Photinus pyralis luciferase do not
work in C. albicans). However, some heterologous gene reporter
systems have been developed. Thus, β-galactosidase activity
encoded by Kluyveromyces lactis LAC4 gene was the first gene
reporter system described in C. albicans [61]. LAC4 mRNA
contains two CUG codons [87], but this does not affect the
enzymatic activity of this reporter. More recently, Renilla
reniformis luciferase, whose gene lacks CUG codons, has been
described as a bioluminescent gene expression reporter in C.
albicans [117]. Furthermore, although the native green
fluorescent protein (GFP) from Aequorea victoria is not
expressed in C. albicans, it has been genetically optimised with
regard to its codon usage, and the GFP-derivative obtained is
efficiently expressed in C. albicans [19]. Another possible
strategy to avoid the genetic code problem is the use of
homologous reporter genes: the URA3 [72] gene as well as the
major exoglucanase gene from C. albicans, XOG1 [33], have
been described. 
These gene reporter systems have different sensitivities and
employ different host strains and detection methods [19, 85].
This makes them more or less useful in each specific
application. In addition, some of them have been adapted to
the construction of in-frame proteins (e.g. LAC4 [61] and URA3
[72]) and in some cases they may be useful in protein
localization studies (e.g. GFP [39]).
Isolation of C. albicans genes Many strategies have been
used for the isolation of C. albicans genes: screening with
heterologous probes, immunological screenings, reverse
genetics, cDNA differential gene expression, and
complementation of S. cerevisiae or C. albicans mutants [85].
Below we shall focus a little more attention on the latter two
methods. Complementation in S. cerevisiae was chosen among
the early strategies used to isolate C. albicans genes because
it is a straightforward system that usually ensures the
functionality of cloned genes [71, 74]. Nevertheless, this strategy
may be unsuccessful due to differences in the transcription and
translation machinery. Complementation of phenotypes of C.
albicans mutants is an arduous task due to the lack of libraries
in efficient vectors. This problem has been overcome although
to date, only nutritional genes have been isolated [34, 75, 86].
In view of the virulence and hyphal formation capacities of C.
albicans, it is clear that S. cerevisiae is probably not the best
model to study these processes.
Expression controlled systems One of the most powerful
tools in the study of gene functions are regulatable promoters.
These allow the construction of mutant strains in which the
protein of interest is overexpressed or, alternatively,
underexpressed. Four C. albicans promoters have been studied
using luciferase as the reported gene. Two of them are phase-
specific (WH11 and OP4); one is constitutive (EF1-2p), and
the other one is regulated by galactose (GAL1) [117]. Other C.
albicans carbon source-regulatable promoters have been also
used in the study of new C. albicans cloned genes: MAL2p
(maltose-inducible/glucose-repressible promoter [7,19]), HEX1p
(glucose-repressible/N-acetylglucosamine-inducible promoter
[70]) or PCK1p (glucose-repressible [120]). The principal goal
in this study would be the description of promoters able to
repress totally the gene under their control. Promoters able to
switch off completely the expression of a given gene would
enable the study of C. albicans essential genes, which are
potential new antifungal targets. Recently, the construction
of a conditional TOP1 C. albicans null mutant strain has been
reported [44]. In this strain, an internal fragment of the first
copy of the TOP1 gene was replaced by the hisG-CaURA3-
hisG cassette, while the second copy was placed under a
maltose-inducible/glucose-repressible promoter (MRP1p).
Under MRP1p repression conditions (glucose), DNA
topoisomerase I activity was undetectable, which suggested
total repression of the promoter. This system could be useful
in the construction of different conditional null mutants of
putative C. albicans essential genes, although more studies
about MRP1 regulation (using reporter genes or mRNA level
studies) are necessary.
A look into the future of C. albicans manipulation The
characteristics of C. albicans make it an interesting model to
understand the hyphal development, pathogenicity and virulence
of fungi. In fact, more and more laboratories are committed to
its study. Nevertheless, it is still necessary to use S. cerevisiae
as a model for the understanding of C. albicans. Unquestionably,
we need more genetic tools to use C. albicans with the same
degree of versatility as S. cerevisiae has been used over the last
twenty years. The completed S. cerevisiae sequencing and the
EUROFAN projects will help to achieve this aim by providing
new tools developed to understand its biological functions. A
physical map of the chromosomes of C. albicans [16, 73] has
been obtained, and some projects involving the sequencing of
the whole genome of this yeast are currently under way
throughout the world, although not in a joint effort, as it was
the case of S. cerevisiae.
Another approach very promising is two-dimensional
analysis of C. albicans proteins. Since the whole of the 
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S. cerevisiae sequence is now known, the sequence of the
different Candida gel spots in many cases should allow us to
identify C. albicans genes which have homologues in S. cerevisiae.
We are presently carrying out this type of analysis using the
proteins secreted by C. albicans regenerating protoplasts.
Dimorphism
Like other pathogenic fungi, C. albicans is dimorphic. This
yeast exhibits a number of different morphological forms under
different environmental conditions; such forms include budding
yeast cells (blastospores, blastoconidia), pseudohyphae
(elongated cells which appear as filamentous cell chains), true
hyphae, and clamydospores [78] (Fig. 1). A blastospore is a
unicellular form of the fungus that divides by budding. This
process of budding involves the growth of new cellular material
from a small, selected site on the blastospore surface. The new
bud usually develops at the pole distal to the birth scar and
initiates a growth phase. Then, nuclear division takes place and
a septum is laid down between the parent and daughter cell
units. The two cell units separate to form blastospores. A hypha
is a long microscopic tube comprising multiple fungal cell units
divided by septa. Germ tube formation is the initial stage in the
yeast-hyphal transition. A blastospore gives rise to new cellular
material in the shape of a cylinder, called a germ tube, which
grows continuously by extension of the distal pole. Mitotic cell
division occurs within the extending hypha and septa are formed
at intervals along the hyphae without interrupting the rate of
extension. Hyphae may arise as branches of already existing
hyphae or by germination of spores. A mycelium is an entire
fungal cellular aggregate that includes hyphae with all their
branches. 
Experimental conditions for germ-tube formation There
are several features essential for in vitro morphological transition
of C. albicans [78]. The earliest workers with C. albicans found
that changes in the growth environment of C. albicans led to
changes in cell shape. However, no one has ever been able to
discover any environmental “morphogen” that acts alone and
under all conditions to provoke the growth of cells from any
C. albicans isolate in only one morphological form. Some
environmental factors that favor the filamentation in C. albicans
are: temperature of 37–40°C, pH around 7.0 and an initial
blastospore concentration not exceeding 106/ml. Also, certain
chemicals, such as N-acetyl-D-glucosamine, amino acids, biotin,
sulfhydryl compounds, heme group, zinc, and serum, etc. are
required. The production of germ-tubes in serum has remained
the method of choice for identifying C. albicans in clinical
specimens. Although serum is excellent at promoting the yeast
to mycelial conversion, unfortunately its chemical complexity
makes it unsuitable for studying the molecular basis for inducing
the hyphal form.
C. albicans seems to be able to regulate its own morphology
under at least two circumstances: as a slow response to adverse
nutrient environments, in general, and as a rapid response to
certain physicochemical conditions. In the latter case,
filamentous forms seem likely to develop under the conditions
of temperature and pH that are found in host tissues in vivo.
Several specific media have been developed for the culture
of C. albicans. Certain defined media will support both growth
forms, the determining factor being either temperature or pH.
In general, the budding phenotype is prevalent at low
temperatures or low pH, while the hyphal phenotype is prevalent
at high temperatures and high pH. A synthetic medium
(composed of a mixture of amino acids) has been described by
Lee in which a switch in pH suffices to guarantee the production
of either the yeast form (pH 4.5) or the hyphal form (pH 6.5),
both being cultured at 37°C [115]. 
Approaches for the study of C. albicans dimorphism
Different approaches have been used to gain insight into the
molecular basis of dimorphism: (i) a classical genetic approach,
based on obtaining morphological mutants; (ii) the “candidate
gene approach”, in which a gene likely to be involved in
dimorphism is identified; and (iii) the use of S. cerevisiae as a
model of filamentous growth (pseudohyphae) for cloning
homologous Candida genes.
(i) Classical approach. Using a classical genetic strategy,
three kinds of morphological mutants have been isolated and
described [77]. The first corresponds to mutants that fail to give
rise to mycelia or to any other kind of filamentous form (F–
phenotype), at least under the conditions that are usually used
to induce hyphal morphogenesis in wild type strains [10, 25,
76]. Mutants of a second kind have usually been selected on
the basis of alterations in their colony morphology. They are
rough-wrinkled to different extents. The altered colonial
morphology correlates with a permanent alteration in
morphogenesis of the cells, which grow permanently as
filamentous forms strongly resembling pseudohyphae. Budding
growth is suppressed in these mutants (Y– phenotype) [89, 90].
Finally a third type of mutants has been obtained using a careful
selection of filamentous forms by successive filtering of
mutagenised populations. These mutants express all types of
morphogenesis in nutrient medium sequentially and do not
require any type of inducer [31]. Parasexual crosses carried out
with pairs of some of these mutants lead to wild type hybrids,
which indicates the existence of several complementation groups
in the pseudomycelial phenotype [30]. However, the diploidy
and asexual life cycle of Candida have hindered extensive
genetic characterization.
(ii) The candidate gene approach. Genes expressed
differentially during morphogenesis have been identified and
Candida strains homozygous for a null allele of the gene have
been constructed. The gene is required for dimorphism if the
null mutant shows a defect in hypha induction.
To isolate genes differentially expressed during dimorphism,
Birse and co-workers [5] prepared a phage cDNA library from
cells in the process of hypha formation. The library was plated
and plaques were hybridized with labelled cDNAs prepared
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from either yeast or hyphae. The following genes were cloned:
PHR1 and ECE1. PHR1 is differentially regulated in response
to the pH of the growth medium. It encodes a putative cell
surface glycoprotein anchored to the membrane by
glycosylphosphatidylinositol (GPI). Deletion of PHR1 results
in a pH-dependent defect in morphogenesis. ECE1 (Extent
of Cell Elongation) expression is not detected when C. albicans
grows as a budding yeast cell but is observed within 30 min
after cells have been induced to form hyphae. ECE1 expression
correlates with the extent of cell elongation. However ECE1-
null mutants display no morphological alterations, showing
that it is not essential for cell elongation or hypha formation
despite the strict morphological regulation of its expression.
Other genes cloned by different research teams and that are
differentially expressed during morphogenesis are: HYR1 [2],
RBF1 [43], CHS2 [36], CHS3, etc. HYR1-, CHS2- and CHS3-
null mutants do not display any obvious morphological
phenotype. However, disruption of RBF1 causes an alteration
in the cell morphology of the filamentous form and may be
involved in the regulation of the yeast-hypha transition. Genetic
inactivation results in stimulation of filamentous growth in both
solid and liquid media, suggesting that Rbf1p would be involved
in the general pathway of the yeast-to-filament transition.
However, it is also possible that the filamentous growth of the
mutants may be mediated indirectly, for example through some
kind of disturbance in nutrient metabolism, general transcription
or translation, or else through an abnormality in chromosome
structure or its segregation.
(iii) The use of S. cerevisiae as a model of filamentous
growth. S. cerevisiae is also a dimorphic organism capable,
under certain nutritional conditions, of switching from a budding
yeast to a filamentous pseudohyphal form (and in the case of
haploid cells the switch leads to invasive growth). The
similarities between the dimorphic switching of S. cerevisiae
and C. albicans suggest that these morphological pathways
may be regulated by similar mechanisms in both organisms.
In S. cerevisiae, the morphological transition is controlled by
signalling components that are also involved in the mating
response of haploid cells. C. albicans contains functional
homologues of Ste7p (Hst7p), Ste12p (Cph1p, a transcription
factor) and Ste20p (Cst20p) that act in a common regulatory
pathway involved in hyphal growth in Candida. Null alleles of
these genes have been constructed in Candida; showing that
homozygous null mutants are defective in hyphal formation
on some media, but these mutants can still be induced to form
hyphae by serum, which implies that serum induction of hyphae
is independent of the MAP kinase cascade [52, 59].
Recently, three important C. albicans genes have been
cloned: TUP1, EFG1, and CLA4. It has been reported that all
of them are important regulators for C. albicans morphogenesis.
TUP1, a transcriptional repressor, controls filament formation
in C. albicans. The tup1 mutant strain of C. albicans displays
constitutive filamentous growth under all conditions tested. A
model for the control of filamentous growth in C. albicans
by TUP1 has been proposed. TUP1 represses the genes
responsible for initiating filamentous growth and this repression
is abolished under inducing environmental conditions [6].
CLA4 encodes a member of the Ste20p family of
serine/threonine protein kinases. Deletion of both alleles
of this gene in C. albicans causes defects in hyphal formation
and drastically reduces C. albicans virulence in the mouse
model [60].
The product encoded by EFG1 is a member of a conserved
class of bHLH (basic helix-loop-helix) proteins that regulate
morphogenetic processes in fungi. This protein plays a dual
role as a transcriptional activator and repressor, whose balanced
activity is essential for the yeast, pseudohyphal and hyphal
morphogenetic stages of C. albicans [120]. Double mutants
efg1 and cph1 fail to produce germ tubes and hyphae under
any condition tested and show reduced in a mouse model [63].
Pathogenicity studies
The pathogenicity of C. albicans makes important
understanding its relationship with the host. 
Experimental animal models Animal models have been
developed to study, from the point of view of the parasite,
virulence determinants and, from the point of view of the host,
the contribution of the different aspects of the immune response
to control the infection; as well as to study the in vivo fungistatic
or fungicidal capacity of different drugs.
In these models, different types of infection are induced,
as will be detailed below, and the ability of Candida to elicit
lesions in different tissues, or even the death of the animals is
analyzed. Of the existing models, the most used is the murine
one since mice are cheaper than rats, guinea-pigs and rabbits,
and because of the similarity of the murine systemic infection
to that found in humans [17, 78, 80].
Types of assays (i) Cutaneous infections. Generally, an
area of the animal’s skin is slightly scarred and the yeast is
inoculated. The development of the skin colonization is
monitored and samples are taken at different times. For more
details, see the review by Ray [95].
(ii) Vaginitis. This is usually induced in ovariectomized and
treated with oestrogen rats [113] and mice [100]. Previously,
untreated hamsters have also been used [37].
(iii) Intestinal infection. These infections are difficult to
induce in adult mice but not in six-day-old ones [24, 40], or in
germ-free mice [13], which are able to retain the infection
for several weeks, thereby enabling its study.
(iv) Systemic infection. Systemic infection with C. albicans
is induced in mice, rats, guinea-pigs and rabbits. Like the above
models, these are sometimes used to assess the efficiency of
antifungal agents although, more recently, they have also been
used to study virulence determinants.
Two types of systemic infections can be set up: lethal, in
which the survival time is measured, and non-lethal, in which
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the severity of the infection is measured by fungal cell counts
(CFUs) in internal organs or by the lesions produced by the
microorganism in them (observed by anatomical pathology
studies).
(v) Other infections: 
- The rat palate candidiasis model is used to study a kind
of lesion frequently occurring in individuals with dentures [65].
- Models of pielonephritis have been developed in rabbits
[84], as well as models of endocarditis [83] and
endophthalmitis [110].
- A murine model has been developed for the study of
muguet: air is injected into the backs of mice and C. albicans
is inoculated into the subcutaneous sac thus formed [53, 88].
Systemic infection in mice We focus on this model in greater
depth because, as mentioned above, it is the one generally used
in virulence studies and in the assessment of antifungal agents.
This model has also been used to study the main mechanisms
of host defence involved in this kind of infection.
The systemic infection that can be induced in mice is very
similar to that found in humans. In both mice and humans, the
main focus of infection occurs in the kidneys and the brain,
which are the most representative organs of the course of the
disease. After intravenous inoculation (through the lateral vein
of the tail), Candida is deposited in lungs, liver, spleen and
kidney, but of all these organs, the only one in which the
infection is established is the kidney, and it is there where it is
possible to follow the course of the disease [78, 80]. When the
number of microorganisms inoculated is lower, the greatest
damage is seen in the brain [80].
As mentioned above, two types of systemic infections can
be set up:
- Lethal. High doses (1 × 107–1 × 106 blastospores per
mouse) are used to induce it. This kind of study normally elicits
an acute infection, and it is usually used to observe the main
differences in mortality among different Candida strains.
Variables usually measured are: median survival time (MST),
the LD50 (number of blastospores able to kill half the mice)
and the rate of dead mice vs. total (D/T).
- Sublethal. Lower doses (1 × 105–5 × 104 blastospores per
mouse) are used to establish a chronic infection. The course of
the infection is usually monitored by the degree of tissue
damage and the fungal load in the most representative organs;
namely brain and kidneys.
Mouse strains Two types of mouse are usually employed.
These are outbred strains and inbred strains. The former are
strains with a broad genetic variability among the members of
the same litter [80]. This type offers the advantage of being
cheaper since they reproduce well, and they can also be
considered to be more representative of a human population.
An example is the CD1 strain (Charles River Breeding
Laboratories). This strain has been reported to show medium
susceptibility to Candida infections.
C. albicans activates complement in vitro and, as it has been
shown by immunofluorescence experiments, also in vivo [114].
C. albicans can activate the classic route of the complement, but
if this is inhibited, it is able to activate the alternative one [50].
Generally, complement factor C5-deficient strains—for example
DBA/2 and A/J (Charles River Breeding Laboratories)—are
characterized by an increased susceptibility to disseminated and
cutaneous candidiasis, and a predominance of the non-protective
Th2 response, and therefore higher levels of tissue colonisation.
By contrast, strains with a functional complement system, such
as Balb/c, CBA/CaH or DBA/1 (Charles River Breeding
Laboratories) develop Th1 immune response (which is protective)
and are more resistant to this disease [1].
Mutant strains These are mice strains with specific
mutations that confer them certain disfunctions of varying
degrees, which allows independent, detailed study of the
different factors involved in the protection against a given
microorganism. However, the immune response functions as
a whole. So, studies with mutant strains can only provide hints
of the relative importance of the different mechanisms of
defence. Despite this, when these murine strains are used to
compare differences in virulence among different Candida
strains, the conclusions are much more reliable.
Examples of such mutants are:
(i) nu/nu: these are athymic mice unable to generate
functional T lymphocytes.
(ii) scid/scid: these strains have a severe deficiency in T and
B lymphocytes and are therefore unable to orchestrate specific
immune responses.
(iii) transgenic mice: these are mice in which some of the
genes whose products are involved in the immune response,
such as cytokines, have been mutated, thus enabling the study
of the role of these factors in an infection: IL-4(–), γIFN(–)
mice [49] or animals deficient for tumor necrosis factor receptor
(TNFR-p55 or TNFR-p75) are available [119].
Resistance to systemic candidiasis As mentioned above,
one of the objectives of animal studies was to analyze the
immune response of the host, because knowledge of the main
factors involved in the response against the yeast could open
new perspectives in therapy against candidiasis, above all in
immunocompromised hosts. Some reviews have appeared
recently [1, 122]. Here, we shall only summarize some of the
most important aspects.
Innate response Many in vivo studies suggest that the
resistance mechanism could be independent of T-cell mediated
immunity. This innate immunity, probably due to neutrophils
and macrophages, is critical for the clearance of acute systemic
infections. It has been demonstrated that neutropenia is a major
risk factor that increases susceptibility to systemic candidiasis
[96, 98] and that depletion of neutrophils in mice (by injecting
them anti-neutropenic monoclonal antibodies) increases
susceptibility to both systemic and vaginal challenges [27].
However, macrophage activation, which seems to be necessary
for the complete expression of resistance against fungal
infections [97], needs T-cell mediated immunity to limit or
eradicate fungal infection.
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TNF also plays a major role in non-specific resistance
against C. albicans. Steinshamn et al. have suggested that
granulocytes would contribute to the regulation of TNF activity
during infection with C. albicans [119].
Adaptative response Resistance to systemic candidiasis in
immune hosts seems to be associated with a predominant Th1
response, with the generation of DTH lymphocytes specific
for C. albicans antigens, and with an increase in the fungicidal
activity of macrophages. Th1 responses are characterized by γIFN
and IL-2 production. Romani et al. have shown the association
of Th1 responses with the production of IL-12, with the
stimulation of inducible nitric oxide synthase (iNOS), and with
increases in the fungicidal capacity of macrophages [99]. In
contrast, susceptible mice undergo a typical Th2 response,
characterized by the predominant production of IL-4 and IL-10
[15], both of which cause a significant decrease in nitric oxide
(NO) production, as well as in the anti-Candida activity of
macrophages. Neutralization (using monoclonal antibodies) of
IL-10 in immunized mice increases their resistance to C. albicans
reinfection [15]. By contrast, IL-4 or IL-10 administration
exacerbates candidiasis in infected mice [121]. Later experiments
by the same group, in which the role of IL-2 was studied [116],
revealed that its production exerts different effects depending on
whether it takes place at the beginning of the infection or when
the infection is installed. These results and others reviewed in
[1, 122] indicate that, despite the existence of general trends,
about which most investigators agree, the immune response
against C. albicans still affords controversial results. Furthermore,
when considering studies in which cytokine production has been
addressed in situ, in different tissues, it should be taken into
account that the pattern of cytokine production depends on factors
such as the route of administration, the dose, the mouse strain
used, the stage of infection, and the tissue analyzed. 
Clinical investigations have revealed the importance of
antibodies against C. albicans for preventing disseminated
candidiasis. From animal studies it has been reported the
protection conferred by immune serum against candidiasis,
mainly when systemic candidiasis were established by in vitro
inoculation of a lethal dose of C. albicans [66]. Nevertheless,
some results are not so optimistic: rabbits treated with C.
albicans hyperimmune serum were not more resistant to in
vitro inoculation than the corresponding controls. Furthermore,
in some cases, SCID mice were as resistant to systemic
candidiasis as immunocompetent mice strains were [122].
It has been postulated that at least some of these protective
antibodies are directed against both mannoproteins [9, 14] and
the heat shock protein hsp90 [67].
Virulence studies with mutant strains In the latest
published studies on virulence, attempts have been made to
attribute responsibility for the pathogenic capacity of Candida
to different genes. 
In these studies, mutant yeast strains have been used,
generated either by classic methods or by gene disruption. Their
virulence has been assessed comparing it with the virulence of
the wild type strain. There are many examples of such a study,
which have addressed the virulence either of auxotrophic mutants
[18, 48, 112, 125, 126] or of other mutants resistant to different
antifungal agents [4, 54]. However, current studies tend to use
mutants in which certain genes assumed to be involved in
pathogenesis have been disrupted. These studies afford insight
into the involvement of a given gene in virulence and, in some
cases, its putative role as a new target for antifungal development.
Nevertheless, regarding this latter aspect, the trend in
pharmaceutical companies is to select molecular targets that are
essential for viability and not only for virulence. This is so
because antifungal agents are above all necessary in patients
with severe immunodeficiencies. In them, fungicidal action is
crucial, and not merely a fungistatic one, with which patients
usually relapse when treatment is discontinued. Despite this,
the knowledge of virulence factors is still important, as it is their
putative application in the development of antifungals [20].
Several genes have been studied: PHR1, regulated by the
pH of the medium and involved in morphogenesis [29]; genes
involved in chitin synthesis [8], MKC1, a MAP kinase involved
in morphogenesis and cellular integrity [23], and a mutant in
which a triple deletion of the secreted aspartyl proteinase genes
SAP4, SAP5, and SAP6 has been induced [103]. In all these
cases, the mutants were less virulent than the wild strains.
Three papers have shown that the deletion of some given genes
lead to major losses of virulence: (i) Zhao et al. have reported that
the FAS2 gene, which is involved in fatty acid synthesis, is
necessary to establish an infection, both by oral inoculation in
rats [125] and by in vitro inoculation in mice [126]. (ii) Leberer
et al. [60] have shown that deletion of a gene CaCLA4, besides
preventing the dimorphic transition (yeast-to-hypha), causes a
great loss in virulence in systemic infections. This of great
importance because it is the first time that a gene has been shown
to be involved in virulence and filamentation, processes whose
interrelationship had hitherto been controversial [101]. Afterwards,
in Fink’s laboratory a mutant strain has been built up in which
the simultaneous deletion of two genes elicits the absence of
filamentation and a significant loss of virulence [63]. 
Although all three mutants mentioned above lost a
considerable amount of virulence, according to our own
criterion, they cannot be considered avirulent because mouse
strains that orchestrate Th1 responses (protective) were used.
Moreover, only one study used a dose of 1 × 107 blastospores,
in this case the mortality rate was 50% of the mice at  day 15
after inoculation [63].
At our laboratory, we have generated, using classical
mutagenesis, a non-filamentous mutant strain of C. albicans
called 92’ [77]. In studies of pathogenesis, this mutant proved
to be completely avirulent: doses of 1 × 107 blastospores killed
neither resistant mouse strains (Th1 inducers) nor sensitive ones
(Th2 inducers). Additionally, nor did this Candida mutant kill
an additional athymic mouse strain used (nu/nu). Note that, in
our hands, this mutant shows a virulence similar to that of the
yeast S. cerevisiae, it being the first avirulent Candida strain
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described. One of the uses of this mutant will be the cloning of
virulence factors. The generation of an efficient dominant marker
in Candida would considerably facilitate this task and would
be of great help in the experimental handling of clinical isolates.
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